13F Data
13F filer · CIK 2041209

Kedalion Capital Management LLP

LONDON, X0 · filing since Q4 2024 · last filing Nov 6, 2026
Reported value
$4.3B
+$77.9M vs prior
Positions
5
New / sold out
3 / 1
Added / reduced
1 / 1
Turnover
22.0%
buys $934.9M · sells $948.4M
Top-10 weight
100.0%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
AddedSPDR SERIES TRUST+9,840,000+28.0%+$883.2M
NewISHARES TRCALL+500,000–+$51.1M
NewWARNER BROS DISCOVERY INC+16,427–+$508.4K
NewARBUTUS BIOPHARMA CORP+20,168–+$96.4K

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedISHARES TR-1,232,000-82.6%$-943.5M
Sold outBLOOM ENERGY CORP-16,000-100.0%$-4.8M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $2.5BQ1 2025: $2.5BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $4.1BQ1 2026: $3.5BQ2 2026: $4.2BQ3 2026: $4.3B
Q4 2024Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1SPDR SERIES TRUSTST STR P500ETF44,970,000$4.0B94.15%
2ISHARES TRCORE S&P500 ETF260,000$199.1M4.64%
3ISHARES TRCALLIBOXX INV CP ETF500,000$51.1M1.19%
4WARNER BROS DISCOVERY INCCOM SER A16,427$508.4K0.01%
5ARBUTUS BIOPHARMA CORPCOM20,168$96.4K0.00%